Cardiac-resynchronization therapy for mild-to-moderate heart failure

New England Journal of Medicine

Volumn 363, Issue 25, 2010, Pages 2385-2395

  Tang, Anthony S L ^a,b   Wells, George A ^b   Talajic, Mario ^c   Arnold, Malcolm O ^d   Sheldon, Robert ^e   Connolly, Stuart ^f   Hohnloser, Stefan H ^h   Nichol, Graham ⁱ   Birnie, David H ^b   Sapp, John L ^g   Yee, Raymond ^d   Healey, Jeffrey S ^f   Rouleau, Jean L ^c   Ignaszewski, A ^j   Dorian, P ^j   Haddad, H ^j   Newman, D ^j   Howlett, J ^j   Mitchell, L B ^j   Roberts, R ^j   Teo, K ^j   Gillis, A ^j   Newton, G ^j   Kerr, F P ^j   Gula, L ^j   Tung, S ^j   Froeschl, M ^j   Froeschl, S ^j   Swiggum, E ^j   Mielniczuk, L ^j   Smith, S ^j   Hessian, R ^j   Fodor, G ^j   Vuurmas, T ^j   Sterns, L ^j   Gardner, M ^j   Thibault, B ^j   Parkash, R ^j   Basta, M ^j   Sivakumaran, S ^j   Green, M ^j   Nery, P ^j   Essebag, V ^j   Higginson, L ^j   Sidhu, K ^j   McKee, G ^j   Ha, A ^j   Theoret Patrick, P ^j   Yetisir, E ^j   Luce, M ^j   Morin, C ^j   Tran, M L ^j   Ryan, J ^j   Williams, K ^j   Gagne, L ^j   Lemery, R ^j   Gollob, M ^j   Posan, E ^j   Keren, A ^j   Redpath, C ^j   Davis, D ^j   Melniczuk, L ^j   Carlin, L ^j   Ewart, G ^j   Baker, A ^j   MacDonald, K ^j   Dunne, R ^j   Fleming, R ^j   Skanes, A C ^j   Klein, G J ^j   Krahn, A D ^j   Gray, C ^j   Jackson, S ^j   Rajda, M ^j   Giddens, K ^j   Carroll, L ^j   Fearon, A ^j   Exner, D V ^j   Kavanagh, K M ^j   Gillis, A M ^j   Duff, H J ^j   Isaac, D L ^j   Wyse, D G ^j   Schroeder, K ^j   Ramadan, D ^j   Cassidy, P ^j   Ellis, L ^j   Dorestijn, P ^j   Sorensen, S ^j   Koshman, M ^j   Doucet, A ^j   Morillo, C A ^j   Nair, G M ^j   Long, L ^j   Malcolm, V ^j   Meyer, W ^j   Carroll, S ^j   Long, J ^j   Kimber, S ^j   Pantano, A ^j   Cujec, B ^j   Gulamhusein, S ^j   Chan, M ^j   Jones, A ^j   Paradon, K ^j   Mulcahey, C ^j   Haykowsky, L ^j   van Schaik, A ^j   Scott, I ^j   Dubuc, M ^j   Gagne P ^j   Guerra, P G ^j   Khairy, P ^j   Macle, L ^j   Roy, D ^j   Aubin, D ^j   Lemarbre, F ^j   Simard, E ^j   Leather, R ^j   Novak, P ^j   McNish, H ^j   Green, A ^j   Bastell, M ^j   Topham, P ^j   Goethe, J W ^j   Duray, G ^j   Israel, C ^j   Coutu, B ^j   Costi, P ^j   De Guise, M ^j   Greiss, I ^j   Lacombe, P ^j   Laramee, P ^j   Raymond, J M ^j   Bergeron, M ^j   Denis, I ^j   Roby, N ^j   Kerr, C ^j   Yeung Lai Wah, J ^j   Honeyman, C ^j   Shepherd, S ^j   Simpson, C ^j   Abdollah, H ^j   Redfearn, D ^j   Barnachuk, A ^j   Veenhuyzen, G ^j   McCans, J ^j   Fair, S ^j   Staples, P ^j   Philippon, F ^j   O'Hara, G ^j   Molin, F ^j   Champagne, J ^j   Blier, L ^j   Gilbert, M ^j   Nault, I ^j   Sarrazin, J F ^j   Charbonneau, L ^j   Wulffhart, Z ^j   Khaykin, Y ^j   Verma, A ^j   Tsang, B ^j   Chun, R ^j   Symmes, J ^j   Srivamadevan, M ^j   Thangaroopan, M ^j   Hacker, P ^j   Patterson, S ^j   Nath, A ^j   Winger, K ^j   Beardsall, M ^j   Kus, T ^j   Frenette, M ^j   Hadjis, T ^j   Sturmer, M ^j   Becker, G ^j   Langlois, A ^j   Fortier, C ^j   Sami, M ^j   Giannetti, N ^j   Coutu, I ^j   Barber, C ^j   Rinne, C ^j   Lowery, D ^j   Janzen, I ^j   Williams, J ^j   Stobie, P ^j   Anderson, H ^j   Di Camillo, C ^j   Ferguson, L ^j   Jenkinson, L ^j   Crystal, E ^j   Lashevsky, I ^j   Lau, C ^j   Daoulah, A ^j   Calton, R ^j   Pekar, A ^j   Letvin, E ^j   Vecchio, J ^j   Lukomsky, M ^j   Yuen, V ^j   Lakhanpal, M ^j   Connors, S ^j   Furey, M ^j   Fagan, S ^j   Matthews, J ^j   Constantine, M ^j   Power, K ^j   Mangat, I ^j   Pinter, A ^j   Korley, V ^j   Ahmad, K ^j   O'Donnell, S ^j   Allan, K ^j   Kowalewski, M ^j   Darling, D ^j   Erdogan, A ^j   Franzen, W ^j   Greiss, H ^j   Steen Muller M K ^j   Sanders, P ^j   Young, G ^j   Stiles, M ^j   John, B ^j   Leong, D ^j   Cehic, D ^j   Shashidhar, ^j   Dimitri, H ^j   Mitchell, A M ^j   Maxwell, V ^j   Nicholls, V ^j   Ayala Parades, F ^j   Roux, J F ^j   Jean, C ^j   Lavallee, L ^j   Cameron, D ^j   Parker, J ^j   Hill, A ^j   Abraham, L ^j   Weiss, C ^j   Himmrich, E ^j   Hink, H U ^j   Mollnau, H ^j   Willems, R ^j   Heidbuchel H ^j   Huybrechts, W ^j   Nuyens, D ^j   Rossenbacker, T ^j   Van Cleemput, J ^j   Vanhaecke, J ^j   Droogne W ^j   Ramdat Misier, A R ^j   Beukema, W P ^j   Delnoy, P P ^j   Elvan, A ^j   Smit, J J ^j   Toal, S ^j   Douglas, G ^j   Searles, G ^j   Fitzgerald, F ^j   Collings, E ^j   Seidl, K ^j   Kleemann, T ^j   Strauss, U ^j   Geller, J C ^j   Can, L H ^j   Hasdemir, C ^j   Labonte R ^j   Juma, Z ^j   Peterson, T ^j   Beausoleil, B ^j   Lai, C ^j   Nigro, F ^j   Maguire, B ^j   Fox, G ^j   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f HAMILTON HEALTH SCIENCES   (Canada)

^g QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^h GOETHE UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; WARFARIN;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 78650215892     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1009540     Document Type: Article

References (24)

1. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. [Erratum, N Engl J Med 2005;352:2146.]
2. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80. (Pubitemid 32224395)
3. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33. (Pubitemid 34628286)
4. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346: 1845-53.
5. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-9.
6. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-94.
7. Sutton MG, Plappert T, Hilpisch KE, et al. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 2006;113:266-72.
8. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
9. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-43.
10. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
11. Tang AS, Wells GA, Arnold M, et al. Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design. Curr Opin Cardiol 2009;24: 1-8.
12. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112(12): e154-e235.
13. Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006;22:23-45. [Erratum, Can J Cardiol 2006;22:271.]
14. Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 1999;319:1492-5.
15. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
16. Chan KL, Tang AS, Achilli A, et al. Functional and echocardiographic improvement following multisite biventricular pacing for congestive heart failure. Can J Cardiol 2003;19:387-90.
17. Ypenburg C, Lancellotti P, Tops LF, et al. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J 2008;29:757-65. (Pubitemid 351431034)
18. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000;102:3053-9. [Erratum, Circulation 2001;103:476.]
19. Ukkonen H, Beanlands RS, Burwash IG, et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 2003; 107:28-31.
20. Moss AJ, Zareba W, Hall J, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
21. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117(21):e350-e408. [Erratum, Circulation 2009;120(5):e34-e35.]
22. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016.
23. León AR, Abraham WT, Curtis AB, et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 2005;46:2348-56.
24. Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace 2009;11:297-302.